New pilot to study how air purification systems can reduce the spread of Covid-19 in the classroom

Tel Aviv, Israel, December 9, 2021/PRNewswire/ - Aura Air, a smart air purification company that provides solutions to make indoor air clean and safe, was selected by the Israeli Ministry of Health and Education to be launched by Prime Minister Naftali Bennett’s new pilot will install air filtration systems in 700 classrooms in Jerusalem. As part of the pilot, the Israeli Ministry of Health and Education will install Aura Air purification systems in approximately 100 educational institutions in the Jerusalem area and will study its impact on the spread of the virus in classrooms.

Aviad Shnaiderman, co-founder and CEO of Aura Air, said: “Using Aura Air’s innovative purification system to protect Israeli schoolchildren from COVID-19 is a national priority. “We have been leading the global development of clean and safe air. As the fight against COVID-19 continues, we are honored to be selected as the pilot. "

More than 150 educational institutions around the world cooperate with Aura Air to protect the air in the classroom.

Israel is an internationally recognized world leader in combating the spread of COVID-19 and is the first country to fully vaccinate most of its citizens with the virus. By implementing Aura Air's smart air purification system in classrooms, they are helping to reduce infection rates and ensure the safety and health of children. The company's advanced data-driven technology makes it very suitable for meeting all the technical requirements of pilots. Aura Air will be able to provide inventory to the school in a short time because it has an assembly plant in Israel.

In August 2019, Aura Air conducted an experiment in General Surgery and Oncology Surgery at Chaim Sheba Medical Center in Tel Aviv, Israel. The purpose of this study is to evaluate Aura Air's ability to clean and purify the air from the coronavirus (IBV). The initial result was breakthrough: 99.9% of the virus was targeted and purified. With the outbreak of COVID-19, the focus of this research has shifted to the prevention of hospital-acquired infections. The company's latest test results at the California Innovative Bioanalysis Laboratory show that Aura's smart air purification system can effectively destroy 99.99% of airborne SARS-CoV-2, including Delta variant particles, in just 60 minutes.

About Aura Air: Aura Air has created the world's most intelligent data-driven air purification system that purifies indoor air while vigilantly monitoring its quality in real time. Aura Air’s award-winning patented technology filters and disinfects indoor air through a unique four-stage purification process that captures and kills 99.9% of viruses, bacteria, bacteria and allergens. Founded in 2018, Aura Air is currently helping to purify the air in homes, hospitals, schools, businesses, hotels, restaurants, buses and nursing homes in more than 50 countries/regions around the world. Aura is headquartered in Israel with global offices in the United States and India. For more information, please visit www.auraair.io.

Media Contact: Maya Peled Maya@auraair.io

View original content and download multimedia: https://www.prnewswire.com/news-releases/aura-air-selected-by-israeli-health-and-education-ministries-to-counter-the-spread-of-covid- 19-in-schools-301441577.html

The stock price of Bellus Health (NASDAQ: BLU), a clinical-stage biotechnology company, soared due to positive clinical trial data. As of 10:30 am Eastern Time on Monday, investors were excited about the company's lead candidate BLU-5937, pushing the stock up 58.4%. Bellus Health’s lead drug candidate is a potential first-in-class P2X3 inhibitor for the treatment of refractory chronic cough (RCC) and eczema-related pruritus.

IGM Biosciences Inc (NASDAQ: IGMS) announced the clinical results of its Phase 1 trial of IGM-2323 in patients with advanced B-cell malignancies. These data were presented at the American Society of Hematology (ASH) annual meeting and exposition. As of September 10, 2021, the data cut-off date, 40 patients were enrolled and received treatment with increasing dose levels of IGM-2323. No dose-limiting toxicity, no adverse neurotoxic events, relatively low incidence of cytokine release syndrome (CRS)

Pfizer said on Monday that it had agreed to acquire Arena Pharmaceuticals Inc. for approximately US$6.7 billion, which made both stocks sharply higher.

Adding this unique healthcare group to your investment portfolio now may generate substantial dividend income in the future.

Karen Jubanyik, MD, emergency physician at Yale University School of Medicine, associate professor at Yale University School of Medicine, co-author of "Overcoming Coronavirus: Strategies to Stay Safe and Deal with the New Normal During the COVID-19 Pandemic", tells us how to not catch up COVID. "All of us must act together and act in the best interest of our community," she said. "If we don't act decisively and swiftly, worse variants are likely to emerge." Continue reading her 5 ways to save lives

Researchers at the University of Oxford announced the results of a study that has not been peer-reviewed on Monday. They analyzed blood samples from participants in a large study who received AstraZeneca-Oxford or Pfizer-BioNTech doses. To study mixed vaccines. The results were released a day after British Prime Minister Boris Johnson warned that two injections were not enough to contain Omicron, after the British health agency's findings last week showed that the booster can significantly restore protection for the variant. According to a study by the University of Oxford, there is no evidence that low levels of Omicron anti-infective antibodies may lead to a higher risk of serious illness, hospitalization or death for people receiving two doses of the approved vaccine.

Dr. Suzanne Judd, an epidemiologist at the Birmingham School of Public Health at the University of Alabama, joined the Yahoo Finance Live to discuss Omicron variants and what measures need to be taken from a public health perspective to combat the epidemic.

COVID fatigue is real, but the facts are also true. The number of cases per day exceeds 130,000 again, hospitals in some states are overcrowded, and the death toll is on the rise. The new variant Omicron is booming because Delta is still everywhere. Dr. Anthony Fauci, the president’s chief medical adviser and director of the National Institute of Allergy and Infectious Diseases, appeared yesterday this week to warn that Omicron is "highly contagious." How can you stay safe? Continue reading Five Life

The acquisition strengthens the pharmaceutical giant's inflammatory bowel disease drug pipeline.

Bristol-Myers Squibb (NYSE: BMY) disclosed for the first time the pre-designated interim analysis results of the third TRANSFORM study of Breyanzi (lisocabtagene maraleucel; liso-cel). Breyanzi reduced the risk of disease progression, death and other events in patients with second-line relapsed or refractory large B-cell lymphoma (LBCL) by 65%, exceeding the standard of treatment. These data support the results in June, and the study has reached proof e

Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") announced that it has received a notice that Wanbang Biopharmaceuticals will stop developing Sirona's SGLT2 inhibitor TFC-039 ("Wanbang ") as a treatment for type 2 diabetes in China.

Many biotech stocks have stagnated in 2021. The largest exchange-traded fund tracking the biotechnology industry has been in the negative territory so far this year. This is why they chose Moderna (Nasdaq: MRNA), Seagen (Nasdaq: SGEN) and Vertex Pharmaceuticals (Nasdaq: VRTX). Prosper Junior Bakiny (Moderna): Until about two years ago, Moderna was a little-known company with no products on the market.

MindBeacon Holdings Inc. ("MindBeacon" or "Company") (TSX: MBCN) is a leading provider of digital psychological and behavioral health treatments, covering the entire care process, and providing the company's multiple marketing and business plans The latest information.

The UK Health and Safety Authority (UKHSA) stated that due to "extraordinarily strong demand", the order for the horizontal flow test (LFT) on the government website has been temporarily suspended.

The writer seems to have lost patience with those who will not be vaccinated against COVID-19. The Portsmouth couple paid tribute to Jim Splaine.

The EDM star died in 2018 when he was only 28 years old.

Experts say that a new variant replaces Delta-it is called Omicron, and it is spreading rapidly. The World Health Organization (WHO) stated that the Omicron variant poses a “high risk” globally-this is what we know.

The doctors first shared their advice on dealing with this situation and preventing cannabis-related incidents.

If you are looking for a simple lifestyle change that has a major positive effect on lowering cholesterol, look at your pantry. Going back to a box of corn flakes, granola and Pop-Tarts, you may find the holy grail of health and low cholesterol: a large tin of rolled oats. You know or may not realize that oatmeal is arguably one of the best breakfasts for lowering cholesterol, says R&D Amber Ingram,

As the coronavirus pandemic approaches the end of its second year, the United States is on the cusp of dying more than 800,000 people from the virus, and no group suffers more suffering than the elderly in the United States. It has always been known that the elderly are more vulnerable, but the scale of the loss is only now fully manifested. In the United States, 75% of people who have died from the virus are 65 years of age or older. That is to say, about 600,000 of the nearly 800,000 people who have died so far. One in 100